首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Biocompatibility of Implanted Diabetes Devices: Part 2: A Review of the Management of Implanted Medical Devices for Diabetes: Trends and Directions
【2h】

Biocompatibility of Implanted Diabetes Devices: Part 2: A Review of the Management of Implanted Medical Devices for Diabetes: Trends and Directions

机译:植入式糖尿病器械的生物相容性:第2部分:糖尿病植入式医疗器械管理的回顾:趋势和方向

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The management of diabetes is progressing rapidly from the use of traditional finger sticks for glucose monitoring and multiple daily injections of insulin to more user-friendly devices and approaches. These advances hold the promise of freeing persons with diabetes from the need for continued daily compliance, thereby improving their quality of life and improving control of their underlying diabetes. An underlying theme to solutions based on percutaneous or fully implanted devices is that the useful lifetime of such devices is often limited by the body's foreign body response. This review briefly outlines general factors associated with point-in-time needle stick approaches to the growing use of short-term percutaneous implants (≤7 days) to the challenges of more extended devices, both technical and regulatory, faced by developers of these devices.
机译:糖尿病的管理正在迅速发展,从使用传统的手指棒进行葡萄糖监测和每天多次注射胰岛素到更加用户友好的设备和方法。这些进步有望将糖尿病患者从持续的日常服从中解放出来,从而改善他们的生活质量并改善对潜在糖尿病的控制。基于经皮或完全植入设备的解决方案的一个基本主题是,此类设备的使用寿命通常受到人体异物反应的限制。这篇综述简要概述了与时间点针刺方法相关的一般因素,这些方法与短期经皮植入物(≤7天)的日益使用,以应对这些设备的开发者面临的技术和法规更广泛的设备的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号